UNICEF ships Indian COVID vaccines to poor nations |
India took a giant and noble step as global supplier of COVID vaccine on 24th February 2021 as tens of thousands of COVID-19 vaccines were shipped under the COVAX agreement to UNICEF designated countries.
Under the COVAX agreement, vaccine doses of the AstraZeneca / Oxford vaccine licensed to the Serum Institute of India are shipped to several low and lower-middle income countries. India`s manufacturing base is playing a critical role to close the gap between rich and poor countries, and in ensuring that vaccines are produced and rolled out to low and lower middle-income countries around the world. India has not only proved its technological prowess as a pharmaceutical major, but the gesture of manufacturing and giving to the world while also dealing with its own population establishes India as a development partner of poor countries.
Dr Yasmin Ali Haque, UNICEF India Representative was at the Serum Institute of India, Pune on a visit at the vaccine manufacturing facility. It is a major step in the global effort to beat this pandemic and a landmark achievement towards global equitable access to these lifesaving vaccines,”.
|
|
|
|